Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 1Infratentorial Neoplasms 1Arnold-Chiari Malformation 1Acetaminophen Exposure 1

Interventions

Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Acetaminophen Exposure × Acetaminophen × Clear all
NCT02911961 2021-09-02

APAP-CYS Protein Adduct Concentrations in Patients With Liver-Directed Therapy Intended to Treat Hepatic Tumors

Denver Health and Hospital Authority

Phase 4 Withdrawn

Acetaminophen Exposure

Data powered by HemOnc (CC BY 4.0) Colophon âš¡